B
BioPlus Co Ltd
KOSDAQ:099430
BioPlus Co Ltd
KOSDAQ:099430
Price:
5 560
KRW
5.7%
Market Closed
Market Cap:
₩342.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
KR |
Multiples-Based Value
The Multiples-Based Value of one BioPlus Co Ltd stock under the Base Case scenario is 7 424.43 KRW. Compared to the current market price of 5 560 KRW, BioPlus Co Ltd is Undervalued by 25%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
7 424.43
KRW
Undervaluation 25%
B
Multiples Across Competitors
Competitors Multiples
BioPlus Co Ltd Competitors
BioPlus Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
342.2B KRW | 3.5 | 21.3 | 9.9 | 11.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.9T JPY | 10.8 | 39.7 | 28.8 | 34.6 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.7B CHF | 3.7 | 39.3 | 15.1 | 29.3 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
38.7B USD | 0 | 0 | 0 | 0 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
96.9B DKK | 3.5 | 24.4 | 12.9 | 15.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.2B USD | 3.3 | 32.1 | 13.9 | 19.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP | 2.5 | 35.2 | 12.2 | 19 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD | 1.2 | -16.4 | 17.3 | 56.1 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
926.8B JPY | 7.1 | 52.4 | 24.8 | 33.8 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
36B CNY | 3.7 | 21.2 | 31.2 | 31.2 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.3B USD | 3.5 | 22.9 | 14.6 | 17.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
